Wetherby Asset Management Inc Genmab A/S Transaction History

Wetherby Asset Management Inc

$2.13 Billion
Q3 2024

A detailed history of Wetherby Asset Management Inc transactions in Genmab A/S stock. As of the latest transaction made, Wetherby Asset Management Inc holds 11,688 shares of GMAB stock, worth $240,655. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,688

Previous 12,811 8.77%

Holding current value

$240,655

Previous $321,000 11.53%

% of portfolio

0.01%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.84 - $28.48 $26,772 - $31,983	-1,123 Reduced 8.77%	11,688 $284,000
Q2 2024 Aug 14, 2024	SELL	$25.13 - $30.27 $33,523 - $40,380	-1,334 Reduced 9.43%	12,811 $321,000
Q1 2024 May 15, 2024	SELL	$26.43 - $32.77 $83,730 - $103,815	-3,168 Reduced 18.3%	14,145 $423,000
Q4 2023 Feb 14, 2024	BUY	$27.94 - $35.44 $5,504 - $6,981	197 Added 1.15%	17,313 $551,000
Q3 2023 Nov 14, 2023	BUY	$35.27 - $42.24 $41,512 - $49,716	1,177 Added 7.38%	17,116 $603,000
Q2 2023 Aug 14, 2023	BUY	$37.4 - $42.94 $3,291 - $3,778	88 Added 0.56%	15,939 $605,000
Q1 2023 May 12, 2023	SELL	$34.88 - $43.22 $29,822 - $36,953	-855 Reduced 5.12%	15,851 $598,000
Q4 2022 Feb 14, 2023	BUY	$33.8 - $47.06 $12,776 - $17,788	378 Added 2.32%	16,706 $708,000
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $134,054 - $1.59 Million	4,253 Added 35.22%	16,328 $525,000
Q2 2022 Aug 15, 2022	SELL	$26.83 - $38.57 $89,585 - $128,785	-3,339 Reduced 21.66%	12,075 $393,000
Q1 2022 May 16, 2022	BUY	$30.95 - $39.68 $31,723 - $40,672	1,025 Added 7.12%	15,414 $558,000
Q4 2021 Feb 14, 2022	BUY	$35.87 - $47.12 $12,841 - $16,868	358 Added 2.55%	14,389 $569,000
Q3 2021 Nov 15, 2021	BUY	$41.55 - $48.72 $44,583 - $52,276	1,073 Added 8.28%	14,031 $613,000
Q2 2021 Aug 16, 2021	SELL	$32.88 - $44.57 $8,877 - $12,033	-270 Reduced 2.04%	12,958 $529,000
Q1 2021 May 14, 2021	SELL	$30.92 - $44.4 $17,809 - $25,574	-576 Reduced 4.17%	13,228 $434,000
Q4 2020 Feb 11, 2021	BUY	$33.66 - $40.76 $422,466 - $511,578	12,551 Added 1001.68%	13,804 $562,000
Q3 2020 Dec 16, 2020	SELL	$33.07 - $38.68 $45,074 - $52,720	-1,363 Reduced 9.17%	13,500 $494,000
Q3 2020 Dec 16, 2020	SELL	$33.07 - $38.68 $405,008 - $473,713	-12,247 Reduced 90.72%	1,253 $46,000
Q3 2020 Nov 13, 2020	BUY	$33.07 - $38.68 $114,091 - $133,446	3,450 Added 30.23%	14,863 $544,000
Q2 2020 Aug 14, 2020	BUY	$20.05 - $33.89 $228,830 - $386,786	11,413 New	11,413 $387,000
Q1 2020 May 06, 2020	SELL	$17.15 - $25.22 $173,077 - $254,520	-10,092 Closed	0 $0
Q4 2019 Jan 28, 2020	BUY	$18.88 - $24.14 $190,536 - $243,620	10,092 New	10,092 $225,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.

Account

Wetherby Asset Management Inc Genmab A/S Transaction History